This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Name of Evaluation | Program Type | Status | Expected Completion Date |
---|---|---|---|
Implementation of a Patient Wait Times Guarantee Pilot Project Fund | Summative Evaluation (Grants & Contributions) (G&Cs) |
Ongoing | March 2010 |
Augmenting Health Canada’s Response to Bovine Spongiform Encephalopathy (BSE) - RSE 1, Phase II of Health Canada’s and the Public Health Agency of Canada’s response to BSE in the Areas of Risk Assessment and Targeted Research = BSE II | Summative Evaluation | Planned | March 2010 |
Natural Health Products | Strategic Evaluation | Ongoing | September 2009 |
Food Safety and Nutrition Quality | Strategic Evaluation | Ongoing | October 2009 |
Medical Devices | Strategic Evaluation | Ongoing | March 2010 |
Climate and Infectious Disease Alert and Response Systems to Protect the Health of Canadians | Program Evaluation | Planned | March 2010 |
Air Quality Health Index and Forecast Program | Program Evaluation | Planned | March 2010 |
Canada’s Clear Air Agenda - Clean Air Regulatory Agenda (Environment Canada Lead) |
Thematic Evaluation | Planned | March 2010 |
Federal Contaminated Sites Action Plan | Summative Evaluation | Planned | March 2010 |
National Anti-Drug Strategy (Justice Canada Lead) |
Horizontal Formative Evaluation (including G&Cs) |
Planned | March 2010 |
Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products | Summative Evaluation | Ongoing | March 2010 |
Children and Youth (Cluster) | Strategic Evaluation (including G&Cs) |
Ongoing | September 2009 |
Communicable Disease Control (Cluster) | Strategic Evaluation (including G&Cs) |
Ongoing | October 2009 |
Continued Implementation of the Labrador Innu Comprehensive Healing Strategy | Summative Evaluation | Ongoing | March 2010 |
Chronic Disease and Injury Prevention (Cluster) | Strategic Evaluation (including G&Cs) |
Planned | March 2010 |
Environmental Health Research (Cluster) | Strategic Evaluation (including G&Cs) |
Planned | March 2010 |
Non-Insured Health Benefits (Cluster) | Strategic Evaluation (including G&Cs) |
Ongoing | March 2010 |
Health Facilities and Capital Program | Strategic Evaluation (including G&Cs) |
Planned | March 2010 |
Name of Evaluation | Program Type | Status | Expected Completion Date |
---|---|---|---|
Veterinary Drugs | Strategic Evaluation | Planned | March 2011 |
Nutrition Promotion | Strategic Evaluation | Planned | March 2011 |
Canada’s Clean Air Agenda - Adaptation Theme (Environment Canada Lead) |
Thematic Evaluation | Planned | March 2011 |
Canada’s Clear Air Agenda - Indoor Air Quality Theme | Thematic Evaluation | Planned | March 2011 |
Protecting Canadians and the Environment from Toxic Substances through a Chemical Management Plan | Summative Evaluation | Planned | March 2011 |
Federal Tobacco Control Strategy | Summative Evaluation | Planned | March 2011 |
Mental Health and Addictions (Cluster) | Strategic Evaluation (including G&Cs) |
Planned | March 2011 |
Environmental Health and Research (Cluster) | Strategic Evaluation (including G&Cs) |
Planned | March 2011 |
Name of Evaluation | Program Type | Status | Expected Completion Date |
---|---|---|---|
Health Care Policy Contribution Program | Summative Evaluation (Contribution) |
Planned | March 2012 |
Biologics | Strategic Evaluation | Planned | March 2012 |
Organ and Tissue Donation and Transplantation Program | Summative Evaluation (G&Cs) |
Planned | March 2012 |
Horizontal Evaluation of the Genomics Research and Development Initiative | Summative Evaluation | Planned | March 2012 |
Environmental Health Guide | Program Evaluation | Planned | March 2012 |
Strengthening and Modernizing Canada’s Safety System for Health, Consumer and Food Products - Consumer Products | Component Evaluation | Planned | March 2012 |
Drug Treatment Funding Program of the National Anti-Drug Strategy | Summative Evaluation (G&Cs) |
Planned | March 2012 |
National Anti-Drug Strategy (Justice Canada Lead) |
Horizontal Summative Evaluation (including G&Cs) |
Planned | March 2012 |
Strengthening and Modernizing Canada’s Safety System for Health, Consumer and Food Products - Pesticide Products | Component Evaluation | Planned | March 2012 |
Primary Care (Cluster) | Strategic Evaluation (including G&Cs) |
Planned | March 2012 |
Transfer (Health Governance and Infrastructure Support) (Cluster) | Strategic Evaluation (Transfer Payment) |
Planned | March 2012 |